Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Sample Extraction Procedure for Plasma Samples – V 2.0

Posted on By

BA-BE Studies: SOP for Sample Extraction Procedure for Plasma Samples – V 2.0

Standard Operating Procedure for Sample Extraction from Plasma in BA/BE Bioanalytical Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/156/2025
Supersedes SOP/BA-BE/156/2022
Page No. Page 1 of 12
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the detailed procedure for extracting analytes from human plasma samples prior to LC-MS/MS or other analytical quantification in bioanalytical labs supporting BA/BE studies.

2. Scope

This SOP applies to all plasma samples processed for pharmacokinetic and bioequivalence analysis using extraction methods such as protein precipitation, solid phase extraction (SPE), or liquid-liquid extraction (LLE).

3.

Responsibilities
  • Analyst: Performs extraction as per method, records all steps, and ensures sample traceability.
  • QA Reviewer: Verifies documentation and investigates any deviation during extraction.
  • Lab Supervisor: Ensures equipment calibration, resource availability, and environmental compliance.

4. Accountability

The Head of Bioanalytical Laboratory is accountable for ensuring validated and consistent extraction procedures to preserve analyte integrity and reproducibility.

5. Procedure

5.1 Preparation Before Extraction

  1. Thaw plasma samples as per SOP (refer SOP/BA-BE/155/2025).
  2. Label extraction tubes and racks appropriately (Sample ID, Batch No., Date).
  3. Prepare required reagents (e.g., internal standards, precipitating agents) under validated conditions.
  4. Ensure cleanliness of all glassware, pipettes, and centrifugation tubes.

5.2 General Protein Precipitation Protocol

  1. Add internal standard (IS) to each thawed plasma sample using calibrated micropipettes.
  2. Vortex each tube for 10 seconds to ensure complete mixing.
  3. Add 3 to 4 volumes of precipitating agent (e.g., acetonitrile or methanol) to 1 volume of plasma.
  4. Vortex again for 1 minute to ensure complete protein precipitation.
  5. Centrifuge samples at 10,000 rpm for 10 minutes at 4°C.
  6. Carefully collect the supernatant into autosampler vials or microcentrifuge tubes for evaporation.

5.3 Optional: Solid Phase Extraction (SPE)

  1. Condition SPE cartridges with methanol and water.
  2. Load plasma sample onto cartridge and allow it to percolate under gravity or vacuum.
  3. Wash cartridges with water or weak buffer to remove impurities.
  4. Elute analyte using strong organic solvent (e.g., methanol or acetonitrile).
  5. Evaporate eluate under nitrogen and reconstitute with mobile phase or suitable solvent.

5.4 Optional: Liquid-Liquid Extraction (LLE)

  1. To each plasma sample, add organic solvent (e.g., ethyl acetate) at a 3:1 ratio.
  2. Shake vigorously on a mechanical shaker for 10–15 minutes.
  3. Centrifuge at 4000 rpm for 5 minutes to separate organic and aqueous layers.
  4. Transfer upper organic layer to a clean tube and evaporate under nitrogen.
  5. Reconstitute with required volume of reconstitution solvent.

5.5 Evaporation and Reconstitution

  1. Evaporate supernatants using nitrogen evaporator at controlled temperature (35–40°C).
  2. Reconstitute dry residue with defined volume of mobile phase (as per validated method).
  3. Vortex to ensure homogeneity and transfer to autosampler vials with caps.

5.6 Precautions During Extraction

  1. Avoid cross-contamination by using new tips, tubes, and gloves per sample.
  2. Do not leave samples unattended at room temperature beyond validated duration.
  3. Use calibrated equipment and perform pipette verification periodically.

5.7 Documentation

  1. Record extraction date, analyst name, reagent lot numbers, and centrifuge RPM/time in Annexure-1: Extraction Worksheet.
  2. Any deviation from method to be justified and signed by QA and Supervisor.

6. Abbreviations

  • BA/BE: Bioavailability/Bioequivalence
  • IS: Internal Standard
  • SPE: Solid Phase Extraction
  • LLE: Liquid-Liquid Extraction
  • LC-MS/MS: Liquid Chromatography – Mass Spectrometry

7. Documents

  1. Extraction Worksheet – Annexure-1
  2. Batch Preparation Checklist – Annexure-2
  3. Centrifugation Log – Annexure-3

8. References

  • ICH M10 Bioanalytical Method Validation Guideline
  • US FDA and EMA Bioanalytical Method Validation Guidance
  • Validated Bioanalytical Method SOPs

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Extraction Worksheet

Date Sample ID Method IS Lot No. Precipitant Used Analyst
17/04/2025 PLS-1003 Protein Precipitation IS-B123 ACN Rajesh Kumar

Annexure-2: Batch Preparation Checklist

Step Status Time Remarks
Thawing Completed 09:30 —
IS Addition Completed 09:45 —

Annexure-3: Centrifugation Log

Date Sample Set RPM Time (min) Temp (°C) Done By
17/04/2025 Set-A 10,000 10 4°C Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
17/04/2025 2.0 Incorporated SPE and LLE alternatives Regulatory Alignment QA Head
See also  BA-BE Studies: SOP for Clinical Trial Facility Cleaning and Hygiene - V 2.0
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Aerosol: SOP for Updating Validation Master Plans for Aerosol Manufacturing – V 2.0
Next Post: Gel Manufacturing: SOP for Operation of Gel Mixing Vessels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version